Sushant Sahastrabuddhe, M.D., M.P.H., M.B.A., is the Associate Director General of the Innovation, Initiatives, and Enterprise Development unit at the International Vaccine Institute (IVI).
Dr. Sahastrabuddhe has been with IVI for 15 years and has led multiple vaccine development programs, including those for typhoid conjugate, chikungunya, and COVID-19 vaccines. He is a medical graduate from India, holds a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health (USA), and an M.B.A. from Indiana University (USA).
Before joining IVI, Dr. Sahastrabuddhe worked with the National AIDS Research Institute under the Indian Council of Medical Research and the International AIDS Vaccine Initiative.
He has authored more than 40 manuscripts and two book chapters, and holds academic affiliations as Adjunct Professor at the College of Medicine, Yonsei University (Republic of Korea); Research Fellow at the Centre International de Recherche en Infectiologie, Team GIMAP, Université Jean Monnet / Université Claude Bernard Lyon 1 (France); and Visiting Professor at the Department of Infectious Disease Epidemiology and Dynamics, Institute of Tropical Medicine, Nagasaki University (Japan).